Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Tzu Fei Wang, Kristen M. Sanfilippo, James Douketis, Anna Falanga, John Karageorgiou, Anthony Maraveyas, Thomas L. Ortel, Gerald Soff, Suresh Vedantham, Jeffrey I. Zwicker

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with cancer have an increased risk of thrombosis requiring anticoagulants and/or antiplatelet agents, and they can also encounter thrombocytopenia due to cancer itself or cancer therapies. They often undergo many procedures such as tissue or bone marrow biopsies, placement of central access lines, diagnostic or therapeutic draining procedures, lumbar puncture, and more. Management of antithrombotic agents or thrombocytopenia around the time of these procedures is highly variable. In this document, the Hemostasis and Malignancy Subcommittee of the International Society on Thrombosis and Haemostasis aims to provide useful practice guidance in the management of antithrombotic agents and thrombocytopenia around the time of common procedures in patients with cancer.

Original languageEnglish
Pages (from-to)3026-3038
Number of pages13
JournalJournal of Thrombosis and Haemostasis
Volume20
Issue number12
DOIs
StatePublished - Dec 2022

Keywords

  • anticoagulation
  • antiplatelet
  • biopsy
  • cancer
  • procedure
  • thrombocytopenia

Fingerprint

Dive into the research topics of 'Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH'. Together they form a unique fingerprint.

Cite this